Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Biomet, Inc.
Point Of Care Diagnostics Market Projected To Continue Rapid Growth
A new report from Informa's Meddevicetracker highlights strong projected growth in the market, explaining the underlying reasons why.
Antios Raises $96m To Advance HBV Drug With Pharmasset Pedigree
Antios thinks ATI-2173, which employs the Pharmasset liver-targeting chemistry used in HCV blockbuster Sovaldi, can help produce a functional cure in hepatitis B combination therapy.
Abbott, BD, Quidel OTC COVID-19 Tests Granted Emergency Use Authorization In US
FDA grants emergency use authorization to OTC COVID-19 testing products as it targets allowing workplaces, schools and communities to access tools needed to screen for the virus rapidly and accurately.
FDA Grants Emergency Use Authorization To Variety Of OTC COVID-19 Tests
The US agency has granted emergency use authorization to consumer COVID-19 testing products from Quidel, Abbott and BD.
- Other Names / Subsidiaries
- Biomet Biologics, Inc.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.